Cardiac Output, Low: Clinical Trials

13 trials for Cardiac Output, Low, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown. 13 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 9, Unknown 4
Phase 23Unknown 2, Completed 1

Follow Cardiac Output, Low: new trials by email Literature Review of Cardiac Output, Low trials Research Report on Cardiac Output, Low

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exogenous Ketones for Acutely Decompensated HEart Failure
25g Ketone monoester without added salts, Placebo - Acute Heart Failure, Low Cardiac Output Syndrome
Phase 3UnknownInstitute for Clinical and Experimental Medicine242020-12-022021-01-06
Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS)
Levosimendan, Placebos - Cardiac Output, Low
Phase 2 / Phase 3UnknownMaría de los Ángeles Tena Pajuelo3002020-06-172020-07-24
Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants
Milrinone, Normal saline - Low Cardiac Output Syndrome, Cardiac Surgical Procedures
Phase 3UnknownShanghai Children's Medical Center5202019-02-012019-01-30
Nitric Oxide During Bypass for Arterial Switch Operation
Nitric Oxide - Low Cardiac Output Syndrome, Transposition of Great Vessels
Phase 3CompletedMurdoch Childrens Research Institute3002018-07-112024-04-18
Liberal Versus Restrictive Use of Dobutamine in Cardiac Surgery
Liberal dobutamine protocol, Restrictive dobutamine protocol - Cardiac Output, Low, Coronary Disease
Phase 3CompletedUniversity of Sao Paulo1602015-02-012022-03-16
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Levosimendan, Placebo - Coronary Artery Bypass Grafting, Mitral Valve Surgery
Phase 3CompletedTenax Therapeutics, Inc.8822014-07-012018-06-21
Preoperative Levosimendan in CABG Patients With Poor LV Function
levosimendan, Placebo - Coronary Artery Bypass Grafting, Left Ventricular Dysfonction
Phase 3CompletedAssistance Publique - Hôpitaux de Paris3352013-06-012016-02-25
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
Remote ischemic preconditioning stimulus, control - Death, Stroke
Phase 3CompletedQueen's University4292012-02-012016-02-05
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low
Phase 2 / Phase 3UnknownUniversity Hospital Birmingham2202009-10-012011-08-11
Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery
Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low
Phase 2 / Phase 3CompletedUniversity Hospital Birmingham2902007-02-012010-05-20
The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients
Hypertonic lactate, Ringer's lactate - Low Cardiac Output
Phase 3CompletedInnogene Kalbiotech Pte. Ltd662005-07-012007-09-14
The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG
adrenaline, milrinone - Cardiac Output, Low
Phase 3CompletedUniversity of Luebeck602003-06-012015-06-03
Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats
Hypertonic lactate, Ringer's lactate - Low Cardiac Output
Phase 3CompletedInnogene Kalbiotech Pte. Ltd2302002-03-012007-09-14

Narrower conditions

Myocardial Reperfusion Injury (2)  ·  Renal Insufficiency (2)  ·  Aortic Valve Stenosis (1)  ·  Coronary Disease (1)  ·  Death (1)  ·  Heart Defects, Congenital (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Ketosis (1)  ·  Myocardial Infarction (1)  ·  Stroke (1)  ·  Transposition of Great Vessels (1)  ·  Ventricular Dysfunction, Left (1)

Broader conditions

Cardiovascular Diseases (13)  ·  Heart Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Signs and Symptoms (13)  ·  Myocardial Ischemia (4)  ·  Vascular Diseases (4)  ·  Pathologic Processes (3)  ·  Cardiomyopathies (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Postoperative Complications (2)  ·  Reperfusion Injury (2)  ·  Urogenital Diseases (2)

Interventions

Simendan (3)  ·  Milrinone (2)  ·  Perhexiline (2)  ·  Ringer's Lactate (2)  ·  Epinephrine (1)  ·  Nitric Oxide (1)  ·  Riboflavin (1)  ·  Saline Solution (1)

Sponsors

Innogene Kalbiotech Pte. Ltd (2)  ·  University Hospital Birmingham (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Institute for Clinical and Experimental Medicine (1)  ·  María de los Ángeles Tena Pajuelo (1)  ·  Murdoch Childrens Research Institute (1)  ·  Queen's University (1)  ·  Shanghai Children's Medical Center (1)  ·  Tenax Therapeutics, Inc. (1)  ·  University of Luebeck (1)  ·  University of Sao Paulo (1)

Countries

Canada (3)  ·  Indonesia (3)  ·  United Kingdom (2)  ·  Australia (1)  ·  Brazil (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Malaysia (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Domeinco Pagano, MD FRCS (2)  ·  Xavier Leverve, MD, PhD (2)  ·  Bernard Cholley, MD, PhD (1)  ·  Darrin Payne, MD (1)  ·  Elisabet B Berastegui Garcia, Cardiac surgery (1)  ·  Gemma S Sanchez Espin, Cardiac Surgery (1)  ·  Huiwen Chen, MD, PhD (1)  ·  Iqbal Mustafa, MD (1)  ·  John Alexander, MD (1)  ·  Juan B Bustamante Munguira, Cardiac surgery (1)  ·  Marc V Vives Santacana, anesthesiology (1)

Results publications

PMID 17470271, PMID 19700350, PMID 23228403, PMID 23620700, PMID 24126568, PMID 24948413, PMID 25734940, PMID 25989324, PMID 27496105, PMID 27686343, PMID 27914501, PMID 28316276, PMID 28787507, PMID 29718383, PMID 33496877, PMID 35263653

NIH funding

2019 (1)